Federica Cicchiello

Monza, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

The evolution of a luminal breast cancer to a triple-negative and its impact on disease control with sacituzumab govitecan.

The evolution of a luminal breast cancer to a triple-negative and its impact on disease control with sacituzumab govitecan.

Journal: Recenti progressi in medicina
Published: October 24, 2024

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study.

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study.

Journal: BMC cancer
Published: April 29, 2022

How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story.

How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story.

Journal: Life (Basel, Switzerland)
Published: January 18, 2022

Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study.

Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study.

Journal: BMC cancer
Published: September 08, 2020

Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale.

Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale.

Journal: European journal of cancer care
Published: February 18, 2020

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

Journal: International journal of breast cancer
Published: June 12, 2017

Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: analysis of 318 patients.

Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: analysis of 318 patients.

Journal: Tumori
Published: October 25, 2016

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study.

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study.

Journal: Breast cancer research and treatment
Published: September 29, 2016

Efficacy and safety of vinorelbine-capecitabine oral metronomic combination in elderly metastatic breast cancer patients: VICTOR-1 study.

Efficacy and safety of vinorelbine-capecitabine oral metronomic combination in elderly metastatic breast cancer patients: VICTOR-1 study.

Journal: Tumori
Published: June 17, 2016

Isolated cardiac metastasis from squamous cell esophageal cancer.

Isolated cardiac metastasis from squamous cell esophageal cancer.

Journal: Tumori
Published: March 26, 2015
Showing 1-10 of 10

Last Updated: 09/26/2026